|
Dexmedetomidine Hydrochloride Group Clinical Trials
1 actively recruiting trial
Also known as: Dexmedetomidine Hydrochloride
Pipeline
Phase 4: 1
Top Sponsors
- Sunnybrook Health Sciences Centre1
Indications
- Signs and Symptoms1
- Neurologic Manifestations1
- Neurobehavioral Manifestations1
- Confusion1
- Central Nervous System Depressants1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.